Group Co-Chair, ECOG-ACRIN Cancer Research Group
Mitchell D. Schnall, MD, PhD, is the Eugene P. Pendergrass Professor of Radiology and Chair of the Radiology Department at the Perelman School of Medicine, University of Pennsylvania. Dr. Schnall is an international leader in translational biomedical and imaging research, working throughout his career across the interface between basic imaging science and clinical medicine to ensure effective integration of radiology research with other medical disciplines. His work has led to fundamental changes in the imaging approaches to breast and prostate cancer, and he continues to have a significant influence on emerging imaging technologies, including those in optical imaging.
Dr. Schnall was elected Group Chair of the American College of Radiology Imaging Network (ACRIN) in 2008, after having served ACRIN as its Deputy Chair from 1999 through 2007. ACRIN is a National Cancer Institute (NCI)-sponsored cancer cooperative group that designs, conducts, and reports on multicenter clinical trials of imaging in cancer and conducts similar research in neurology and cardiovascular through non-NCI funding. Among the multiple ACRIN clinical studies under his direction are the National Lung Screening Trial, Digital Mammography Imaging Screening Trial, and the National CT Colonography Trial. Dr. Schnall is Co-Principal Investigator of the Center for Magnetic Resonance and Optical Imaging, a National Institutes of Health-funded regional resource at the University of Pennsylvania.
Dr. Schnall maintains active membership in The American Society for Clinical Investigation, the Association of American Physicians, the American Society of Clinical Oncology, and the Radiological Society of North America. He received his undergraduate, medical, and doctorate degrees from the University of Pennsylvania, where he has served on the faculty of the Radiology Department since 1991 and as full professor since 2002. In 2012, he was named Chair of the Radiology Department. Dr. Schnall is a Senior Fellow of the Leonard Davis Institute of Health Economics. He was elected to the Institute of Medicine, one of the most highly regarded honors in biomedicine, in 2012.
|Scientific Planning and Review|
|Biostatistics and Data Management|
|Active Clinical Trials|